Is atherosclerosis a mitochondrial disorder?

Vasa - Journal of Vascular Diseases

Volumn 36, Issue 4, 2007, Pages 229-240

  Finsterer, J ^a,b  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b NONE   (Austria)

Author keywords

Apoptosis; Atherothrombosis; Oxidative phosphorylation; Oxidative stress; Respiratory chain; Vascular damage

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANGIOTENSIN II; ANTIOXIDANT; ARGININE; ASCORBIC ACID; AURANTIIN; BETA CAROTENE; CASPASE; CITRULLINE; COPPER; CREATINE; GLUTAMINE; GLUTATHIONE; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN; MAGNOLOL; MANGANESE; OXYSTEROL; POLYPHENOL DERIVATIVE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RETINOL; SELENIUM; SUPEROXIDE DISMUTASE; TAURINE; ZINC;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; DIET THERAPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE; GENE THERAPY; HOMEOSTASIS; HUMAN; LIPID PEROXIDATION; MACROPHAGE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; RESPIRATORY CHAIN; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VITAMIN SUPPLEMENTATION;

ATHEROSCLEROSIS; CASPASES; DNA DAMAGE; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; ENDOTHELIUM, VASCULAR; HUMANS; LIPID PEROXIDATION; MITOCHONDRIAL DISEASES; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 37149007657     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.36.4.229     Document Type: Review

References (93)

1. Alladina SJ, Song JH, Davidge ST, Hao C, Easton AS. TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2. J Vasc Res 2005; 42: 337-47.
2. Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, Yamazaki K, Nakabayashi M, Ogihara T, Kaneda Y. Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001; 38: 48-55.
3. Bakker SJ, IJzerman RG, Teerlink T, Westerhoff HV, Gans RO, Heine RJ. Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure? Atherosclerosis 2000; 148: 17-21.
4. Ballinger SW. Mitochondrial dysfunction in cardio-vascular disease. Free Radic Biol Med 2005; 38: 1278-95.
5. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, McIntyre K, Runge MS. Mitochondrial integrity and function in atherogenesis. Circulation 2002; 106: 544-9.
6. Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, Runge MS. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 2000; 86: 960-6.
7. Basta G, Lazzerini G, Del Turco S, Ratto GM, Schmidt AM, De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 2005; 25: 1401-7.
8. Berthier A, Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Pais de Barros JP, Monier S, Gambert P, Lizard G, Neel D. 7-Ketocholesterol-induced apoptosis. Involvement of several proapoptotic but also anti-apoptotic calcium-dependent transduction pathways. FEBS J 2005; 272: 3093-104.
9. Bhunia AK, Schwarzmann G, Chatterjee S. GD3 recruits reactive oxygen species to induce cell proliferation and apoptosis in human aortic smooth muscle cells. J Biol Chem 2002; 277: 16396-402.
10. Bhunia AK, Han H, Snowden A, Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem 1997; 272: 15642-9.
11. Botto N, Berti S, Manfredi S, Al-Jabri A, Federici C, Clerico A, Ciofini E, Biagini A, Andreassi MG. Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutat Res 2005; 570: 81-8.
12. Brass EP, Hiatt WR. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med 2000; 5: 55-9.
13. Brigelius-Flohe R, Kluth D, Banning A. Is there a future for antioxidants in atherogenesis? Mol Nutr Food Res 2005; 49: 1083-9.
14. Cane A, Breton M, Koumanov K, Bereziat G, Colard O. Oxidant-induced arachidonic acid release and impairment of fatty acid acylation in vascular smooth muscle cells. Am J Physiol 1998; 274: C1040-6.
15. Carlisle R, Rhoads CA, Aw TY, Harrison L. Endothelial cells maintain a reduced redox environment even as mitochondrial function declines. Am J Physiol Cell Physiol 2002; 283: C1675-86.
16. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691-728.
17. Chen JH, Wu CC, Hsiao G, Yen MH. Magnolol induces apoptosis in vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 2003; 368: 127-33.
18. Chowdhury I, Tharakan B, Bhat GK. Current concepts in apoptosis: The physiological suicide program revisited. Cell Mol Biol Lett 2006; 11: 506-25.
19. Das DK, Maulik N. Mitochondrial function in cardiomyocytes: target for cardioprotection. Curr Opin Anaesthesiol 2005; 18: 77-82.
20. Dayanandan A, Kumar P, Panneerselvam C. Protective role of L-carnitine on liver and heart lipid peroxidation in atherosclerotic rats. J Nutr Biochem 2001; 12: 254-7.
21. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardio-vascular diseases. J Hypertens 2000; 18: 655-73.
22. Dimmeler S, Zeiher AM. Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul Pept 2000; 90: 19-25.
23. Er E, Oliver L, Cartron PF, Juin P, Manon S, Vallette FM. Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta 2006; 1757: 1301-11.
24. Feigenbaum A, Bergeron C, Richardson R, Wherrett J, Robinson B, Weksberg R. Premature atherosclerosis with photomyoclonic epilepsy, deafness, diabetes mellitus, nephropathy, and neurodegenerative disorder in two brothers: a new syndrome? Am J Med Genet 1994; 49: 118-24.
25. Ferrari R. The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol 1996; 28(suppl 1): S1-10.
26. Fisler JS, Warden CH. Uncoupling proteins, dietary fat and the metabolic syndrome. Nutr Metab (Lond) 2006; 3: 38.
27. Fraley AE, Tsimikas S. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr Opin Lipidol 2006; 17: 502-9.
28. Furuya R, Odamaki M, Kumagai H, Hishida A. Impact of angiotensin II receptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal dialysis patients. Blood Purif 2006; 24: 445-50.
29. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006; 114: 597-605.
30. Granville DJ, Cassidy BA, Ruehlmann DO, Choy JC, Brenner C, Kroemer G, van Breemen C, Margaron P, Hunt DW, McManus BM. Mitochondrial release of apoptosis-inducing factor and cytochrome c during smooth muscle cell apoptosis. Am J Pathol 2001; 159: 305-11.
31. Guest TM, Vlastos G, Alameddine FM, Taylor WR. Mechano-regulation of monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Antioxid Redox Signal 2006; 8: 1461-71.
32. Han D, Hanawa N, Saberi B, Kaplowitz N. Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic Biol Med 2006; 41: 627-39.
33. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev 2006; 38: 171-96.
34. Hong H, Liu GQ. Scutellarin protects PC12 cells from oxidative stress-induced apoptosis. J Asian Nat Prod Res 2006; 8: 471-9.
35. Hool LC. Reactive oxygen species in cardiac signalling: from mitochondria to plasma membrane ion channels. Clin Exp Pharmacol Physiol 2006; 33: 146-51.
36. Jeon SM, Bok SH, Jang MK, Lee MK, Nam KT, Park YB, Rhee SJ, Choi MS. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci 2001; 69: 2855-66.
37. Kals J, Kampus P, Kals M, Zilmer K, Kullisaar T, Teesalu R, Pulges A, Zilmer M. Impact of oxidative stress on arterial elasticity in patients with atherosclerosis. Am J Hypertens 2006; 19: 902-8.
38. Kamat JP. Peroxynitrite: a potent oxidizing and nitrating agent. Indian J Exp Biol 2006; 44: 436-47.
39. Kamphorst W, Haasnoot KJ, Wegener RP, Dorsman WH. A congenital syndrome of mental deficiency, gait disturbance, sensorineural deafness and pigmentary retinopathy associated with premature atherosclerosis. Clin Neuropathol 1995; 14: 211-5.
40. Kinscherf R, Deigner HP, Usinger C, Pill J, Wagner M, Kamencic H, Hou D, Chen M, Schmiedt W, Schrader M, Kovacs G, Kato K, Metz J. Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 1997; 11: 1317-28.
41. Kokaze A, Ishikawa M, Matsunaga N, Yoshida M, Sekine Y, Teruya K, Takeda N, Sumiya Y, Uchida Y, Takashima Y. Association of the mitochondrial DNA 5178 A/C polymorphism with serum lipid levels in the Japanese population. Hum Genet 2001; 109: 521-5.
42. Korga A, Korobowicz E, Dudka J. Role of mitochondrial protein Smac/Diablo in regulation of apoptotic pathways. Pol Merkuriusz Lek 2006; 20: 573-6.
43. Kurata A, Nishizawa H, Kihara S, Maeda N, Sonoda M, Okada T, Ohashi K, Hibuse T, Fujita K, Yasui A, Hiuge A, Kumada M, Kuriyama H, Shimomura I, Funahashi T. Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 2006; 70: 1717-24.
44. Kyoko U, Seiji U, Shinichi I, Masakazu T, Shinji K, Tohru F, Masunori M. Comparative effects of pitavastatin and probucol on oxidative stress, Cu/Zn superoxide dismutase, PPAR{gamma}, and aortic stiffness in hypercholesterolemia. Am J Physiol Heart Circ Physiol 2006; (in press).
45. Leborgne L, Pakala R, Dilcher C, Hellinga D, Seabron R, Tio FO, Waksman R. Effect of antioxidants on atherosclerotic plaque formation in balloon-denuded and irradiated hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2005; 46: 540-7.
46. Lee SJ, Kim KM, Namkoong S, Kim CK, Kang YC, Lee H, Ha KS, Han JA, Chung HT, Kwon YG, Kim YM. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem 2005;280:5781-8.
47. Lehr HA, Frei B, Olofsson AM, Carew TE, Arfors KE. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 1995; 91: 1525-32.
48. Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 1332-40.
49. Lesauskaite V, Ivanoviene L, Valanciute A. Programmed cellular death and atherogenesis: from molecular mechanisms to clinical aspects. Medicina (Kaunas) 2003; 39: 529-34.
50. Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1014-30.
51. Li M, Absher PM, Liang P, Russell JC, Sobel BE, Fukagawa NK. High glucose concentrations induce oxidative damage to mitochondrial DNA in explanted vascular smooth muscle cells. Exp Biol Med (Maywood) 2001; 226: 450-7.
52. Liu H, Zheng F, Li Z, Uribarri J, Ren B, Hutter R, Tunstead JR, Badimon J, Striker GE, Vlassara H. Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. Am J Pathol 2006; 169: 303-13.
53. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, Zhou ZM, Zhou M, Xie D, Wang GB, Zhang X. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 2006; 26: 1156-62.
54. Madamanchi NR, Tchivilev I, Runge M. Genetic markers of oxidative stress and coronary atherosclerosis. Curr Atheroscler Rep 2006; 8: 177-83.
55. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
56. Matsunaga T, Iguchi K, Nakajima T, Koyama I, Miyazaki T, Inoue I, Kawai S, Katayama S, Hirano K, Hokari S, Komoda T. Glycated high-density lipoprotein induces apoptosis of endothelial cells via a mitochondrial dysfunction. Biochem Biophys Res Commun 2001; 287: 714-20.
57. Mehta JL, Rasouli N, Sinha AK, Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol 2006; 38: 794-803.
58. Mohan SN, Koyoma K, Thangasamy A, Nakano H, Glickman RD, Mohan N. Low shear stress preferentially enhances IKK activity through selective sources of reactive oxygen species for persistent activation of NF-k{beta} in endothelial cells. Am J Physiol Cell Physiol 2006; (in press).
59. Moon SK, Kang SK, Kim CH. Reactive oxygen species mediates disialoganglioside GD3-induced inhibition of ERK1/2 and matrix metalloproteinase-9 expression in vascular smooth muscle cells. FASEB J 2006; 20: 1387-95.
60. Nanami M, Ookawara T, Otaki Y, Ito K, Moriguchi R, Miyagawa K, Hasuike Y, Izumi M, Eguchi H, Suzuki K, Nakanishi T. Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells. Arterioscler Thromb Vasc Biol 2005; 25: 2495-501.
61. Nofer JR, Levkau B, Wolinska I, Junker R, Fobker M, von Eckardstein A, Seedorf U, Assmann G. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 2001; 276: 34480-5.
62. Nomiyama T, Tanaka Y, Piao L, Hattori N, Uchino H, Watada H, Kawamori R, Ohta S. Accumulation of somatic mutation in mitochondrial DNA and atherosclerosis in diabetic patients. Ann N Y Acad Sci 2004; 1011: 193-204.
63. O'Donnell V, Burkitt MJ. Mitochondrial metabolism of a hydroperoxide to free radicals in human endothelial cells: an electron spin resonance spin-trapping investigation. Biochem J 1994; 304: 707-13.
64. Okabe TA, Kishimoto C, Shimada K, Murayama T, Yokode M, Kita T. Effects of MCI-186 (edaravone), a novel free radical scavenger, upon experimental atherosclerosis in apolipoprotein E-deficient mice. Circ J 2006; 70: 1216-9.
65. Oliveira HC, Cosso RG, Alberici LC, Maciel EN, Salerno AG, Dorighello GG, Velho JA, de Faria EC, Vercesi AE. Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J 2005; 19: 278-80.
66. Park JY, Park KG, Kim HJ, Kang HG, Ahn JD, Kim HS, Kim YM, Son SM, Kim IJ, Kim YK, Kim CD, Lee KU, Lee IK. The effects of the overexpression of recombinant uncoupling protein 2 on proliferation, migration and plasminogen activator inhibitor 1 expression in human vascular smooth muscle cells. Diabetologia 2005; 48: 1022-8.
67. Perez-de-Arce K, Foncea R, Leighton F. Reactive oxygen species mediates homocysteine-induced mitochondrial biogenesis in human endothelial cells: modulation by antioxidants. Biochem Biophys Res Commun 2005; 338: 1103-9.
68. Puddu P, Puddu GM, Galletti L, Cravero E, Muscari A. Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis. Cardiology 2005; 103: 137-41.
69. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000; 20: 645-51.
70. Ramachandran A, Levonen AL, Brookes PS, Ceaser E, Shiva S, Barone MC, Darley-Usmar V. Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radic Biol Med 2002; 33: 1465-74.
71. Rapava EA, Akhvlediani MV, Emukhvari MG. Modern view on biochemistry of atherosclerosis. Georgian Med News 2006; 133: 124-8.
72. Roucou X, Antonsson B, Martinou JC. Involvement of mitochondria in apoptosis. Cardiol Clin 2001; 19: 45-55.
73. Ryan L, O'Callaghan YC, O'Brien NM. The role of the mitochondria in apoptosis induced by 7beta-hydroxycholesterol and cholesterol-5beta,6beta- epoxide. Br J Nutr 2005; 94: 519-25.
74. Sayed-Ahmed MM, Khattab MM, Gad MZ, Mostafa N. L-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits. Pharmacol Res 2001; 44: 235-42.
75. Schreck R, Baeuerle PA. A role for oxygen radicals as second messengers. Trends Cell Biol 1991; 1: 39-42.
76. Schroecksnadel K, Frick B, Winkler C, Fuchs D. Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease. Curr Vasc Pharmacol 2006; 4: 205-13.
77. Schulman IH, Zhou MS, Raij L. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. J Hypertens Suppl 2006; 24: S45-50.
78. Schulz R, Rassaf T, Massion PB, Keim M, Balligand JL. Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. Pharmacol Ther 2005; 108: 225-56.
79. Shanahan CM, Carpenter KL, Cary NR. A potential role for sterol 27-hydroxylase in atherogenesis. Atherosclerosis 2001; 154: 269-76.
80. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 2006; 13: 129-42.
81. Stöllberger C, Finsterer J. Atherosclerosis: infection-induced involvement of mitochondrial chaperonins. Lancet 2003; 362: 1949-50.
82. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995; 270: 296-9.
83. Szeto HH. Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J 2006; 8: E277-83.
84. Ungvari Z, Gupte SA, Recchia FA, Batkai S, Pacher P. Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 2005; 3: 221-9.
85. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
86. van de Vijver LP, Weber C, Kardinaal AF, Grobbee DE, Princen HM, van Poppel G. Plasma coenzyme Q10 concentrations are not decreased in male patients with coronary atherosclerosis. Free Radic Res 1999; 30: 165-72.
87. Walter DH, Haendeler J, Galle J, Zeiher AM, Dimmeier S. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation 1998; 98: 1153-7.
88. Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004; 306: 1190-4.
89. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276: 25096-100.
90. Yang F, Tan HM, Wang H. Hyperhomocysteinemia and atherosclerosis. Sheng Li Xue Bao 2005; 57: 103-14.
91. Yang Z, Ming XF. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 2006; 4: 53-65.
92. Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res 2006; 29: 457-66.
93. Yuen B, Furrer L, Ballmer PE. Antioxidant vitamin supplementation in the prevention of cardiovascular Disease. Ther Umsch 2005; 62: 615-8.